1. PMDA: package insert revisions needed for four drugs in Japan

   News item 19 August 2017 Pages: 1 - 1

2. Serious AEs with compounded curcumin emulsion product

   News item 19 August 2017 Pages: 2 - 2

3. Teriflunomide: kidney-related risks assessed by Health Canada

   News item 19 August 2017 Pages: 3 - 3

4. Adverse drug events/medication errors in mental health hospitals

   Clinical study 19 August 2017 Pages: 4 - 4

5. Antidepressant-induced liver injury risk in Italy

   Clinical study 19 August 2017 Pages: 5 - 5

6. Cardiac events with sofosbuvir: systematic review, meta-analysis

   Clinical study 19 August 2017 Pages: 6 - 6

7. Coroners' reports: important data to prevent future deaths

   Epidemiology clinical study 19 August 2017 Pages: 7 - 7

8. Patient engagement strategies may improve medication safety

   Clinical study 19 August 2017 Pages: 8 - 8

9. Risk of ICDs with aripiprazole: US and European data concur

   Clinical study 19 August 2017 Pages: 9 - 9

10. Severe terbinafine-associated liver injury

    Clinical study 19 August 2017 Pages: 10 - 10

11. WHO GVS-MCC study: feasible and generates valid data

    Clinical study 19 August 2017 Pages: 11 - 11

12. Acenocoumarol/enoxaparin sodium

    Case report 19 August 2017 Pages: 12 - 12

13. Adalimumab

    Case report 19 August 2017 Pages: 13 - 13

14. Ajmaline/orciprenaline

    Case report 19 August 2017 Pages: 14 - 14

15. Alcohol

    Case report 19 August 2017 Pages: 15 - 15

16. Alcohol

    Case report 19 August 2017 Pages: 16 - 16

17. Alemtuzumab

    Case report 19 August 2017 Pages: 17 - 17

18. Alfacalcidol/calcium carbonate

    Case report 19 August 2017 Pages: 18 - 18

19. Allopurinol

    Case report 19 August 2017 Pages: 19 - 19

20. Allopurinol

    Case report 19 August 2017 Pages: 20 - 20

21. Allopurinol

    Case report 19 August 2017 Pages: 21 - 21

22. Alteplase

    Case report 19 August 2017 Pages: 22 - 22

23. Alteplase/aspirin

    Case report 19 August 2017 Pages: 23 - 23

24. Amikacin/antituberculars

    Case report 19 August 2017 Pages: 24 - 24

25. Amiodarone

    Case report 19 August 2017 Pages: 25 - 25

26. Anastrozole

    Case report 19 August 2017 Pages: 26 - 26

27. Anticoagulants/bevacizumab

    Case report 19 August 2017 Pages: 27 - 27

28. Antineoplastics

    Case report 19 August 2017 Pages: 28 - 28

29. Antineoplastics

    Case report 19 August 2017 Pages: 29 - 29

30. Antineoplastics

    Case report 19 August 2017 Pages: 30 - 30

31. Antineoplastics

    Case report 19 August 2017 Pages: 31 - 31

32. Antineoplastics

    Case report 19 August 2017 Pages: 32 - 32

33. Antineoplastics

    Case report 19 August 2017 Pages: 33 - 33

34. Antineoplastics

    Case report 19 August 2017 Pages: 34 - 34

35. Antineoplastics

    Case report 19 August 2017 Pages: 35 - 35

36. Antineoplastics

    Case report 19 August 2017 Pages: 36 - 36

37. Antineoplastics/nivolumab/pembrolizumab

    Case report 19 August 2017 Pages: 37 - 37

38. Antineoplastics/pegfilgrastim

    Case report 19 August 2017 Pages: 38 - 38

39. Antineoplastics/peplomycin

    Case report 19 August 2017 Pages: 39 - 39

40. Antiretrovirals/rivaroxaban interaction

    Case report 19 August 2017 Pages: 40 - 40

41. Antithymocyte globulin

    Case report 19 August 2017 Pages: 41 - 41

42. Antituberculars

    Case report 19 August 2017 Pages: 42 - 42

43. Antivirals

    Case report 19 August 2017 Pages: 43 - 43

44. Azathioprine/budesonide/infliximab

    Case report 19 August 2017 Pages: 44 - 44

45. Azathioprine/cyclophosphamide

    Case report 19 August 2017 Pages: 45 - 45

46. Azathioprine/methotrexate

    Case report 19 August 2017 Pages: 46 - 46

47. Azithromycin/pneumococcal vaccine

    Case report 19 August 2017 Pages: 47 - 47

48. Bee-venom-allergy-immunotherapy

    Case report 19 August 2017 Pages: 48 - 48

49. Bendamustine

    Case report 19 August 2017 Pages: 49 - 49

50. Bendamustine

    Case report 19 August 2017 Pages: 50 - 50